Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Os Therapies Incorporated (OSTX)

Os Therapies Incorporated (OSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 48,899
  • Shares Outstanding, K 21,928
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,790 K
  • EBIT $ -5 M
  • EBITDA $ -2 M
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.14
  • Number of Estimates 1
  • High Estimate -0.14
  • Low Estimate -0.14
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.71 +30.41%
on 02/03/25
7.00 -68.14%
on 01/15/25
-1.93 (-46.39%)
since 01/14/25
3-Month
1.58 +41.14%
on 11/19/24
7.00 -68.14%
on 01/15/25
+0.03 (+1.36%)
since 11/14/24

Most Recent Stories

More News
RedChip Launches RedChat: Revolutionary AI Chatbot for Small-Cap Stock Analysis

RedChat provides data-driven precision, real-time efficiency, and comprehensive coverage

BFRG : 3.65 (-7.70%)
SXTP : 0.5910 (-5.61%)
GRRR : 26.57 (-12.43%)
CNTM : 0.9400 (+0.37%)
OSTX : 2.23 (+12.06%)
RedChip Launches RedChat: Revolutionary AI Chatbot for Small-Cap Stock Analysis

RedChat provides data-driven precision, real-time efficiency, and comprehensive coverage

BFRG : 3.65 (-7.70%)
SXTP : 0.5910 (-5.61%)
GRRR : 26.57 (-12.43%)
CNTM : 0.9400 (+0.37%)
OSTX : 2.23 (+12.06%)
Kairos, OS Therapies, AEON See Highest Weekly Spike In Retail Following Among Biotechs: Here's Why

Cancer treatments, FDA breakthroughs, and other developments fueled a sharp spike in interest for these biotech players, as investors bet on promising clinical data and strategic moves.

KAPA : 1.3700 (-5.52%)
OSTX : 2.23 (+12.06%)
AEON : 0.1290 (-0.77%)
Cancer Care Disruptions Highlight Growing Demand for Innovative Oncology Treatments

/CNW/ -- USA News Group News Commentary – The American Cancer Society recently released its Advances in Oncology – 2024 Research Highlights report that...

ONCY : 0.7672 (-0.63%)
CKPT : 3.31 (-4.34%)
LLY : 844.27 (-3.00%)
ONC.TO : 1.11 (+0.91%)
OSTX : 2.23 (+12.06%)
CRDF : 4.29 (+3.37%)

Business Summary

OS Therapies Incorporated is a clinical stage oncology company focused on the identification, development and commercialization of treatments for Osteosarcoma and other solid tumors. The company's lead asset consists OST-HER2. OS Therapies Incorporated is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 3.57
2nd Resistance Point 3.28
1st Resistance Point 2.75
Last Price 2.23
1st Support Level 1.93
2nd Support Level 1.64
3rd Support Level 1.11

See More

52-Week High 7.00
Fibonacci 61.8% 4.93
Fibonacci 50% 4.29
Fibonacci 38.2% 3.65
Last Price 2.23
52-Week Low 1.58

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar